Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease

One third of patients with inflammatory bowel disease (IBD) inadequately respond to anti-TNF treatment and preclinical data suggest that matrix metalloproteinase-9 (MMP-9) is a novel therapeutic target. Here we show that IBD clinical and histopathological parameters found in wild type mice challenge...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bruyn, Magali, Breynaert, Christine, Arijs, Ingrid, De Hertogh, Gert, Geboes, Karel, Thijs, Greet, Matteoli, Gianluca, Hu, Jialiang, Van Damme, Jo, Arnold, Bernd, Ferrante, Marc, Vermeire, Séverine, Van Assche, Gert, Opdenakker, Ghislain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460016/
https://www.ncbi.nlm.nih.gov/pubmed/28561062
http://dx.doi.org/10.1038/ncomms15384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460016/
https://www.ncbi.nlm.nih.gov/pubmed/28561062
http://dx.doi.org/10.1038/ncomms15384

Ejemplares similares